Cargando…
DXA assessment and fracture prevention in hormone positive breast cancer patients after treatment initiation with aromatase inhibitors: A registry-based cohort study
BACKGROUND: Several guidelines have been proposed to prevent aromatase inhibitors induced bone loss (AIBL), but there is scarce data on their endorsement in clinical practice. AIM: To assess bone health evaluation and fracture prevention in postmenopausal women with estrogen receptor (ER)-positive b...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474058/ https://www.ncbi.nlm.nih.gov/pubmed/37664159 http://dx.doi.org/10.1016/j.jbo.2023.100501 |